• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COCHLEAR LIMITED NUCLEUS CI512 COCHLEAR IMPLANT WITH CONTOUR ADVANCE ELECTRODE; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COCHLEAR LIMITED NUCLEUS CI512 COCHLEAR IMPLANT WITH CONTOUR ADVANCE ELECTRODE; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number CI512
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Unspecified Infection (1930); Necrosis (1971); Pain (1994); Skin Infection (4544); Skin Inflammation/ Irritation (4545)
Event Date 01/30/2023
Event Type  Injury  
Manufacturer Narrative
This report is submitted on october 05, 2022.
 
Event Description
Per the clinic, the patient underwent an mri on (b)(6) 2020 and experienced pain and chronic dermatitis after the mri.The patient was hospitalized on (b)(6) 2022 due to infection at the implant site.Subsequently, the patient was treated with oral and iv antibiotics (specific date and duration not reported) during hospitalization.The patient was discharged on (b)(6) 2022 and was prescribed with oral and topical antibiotics (specific date and duration not reported).Surgery to replace the implant magnet is planned but had not taken place at the time of this report.Additional information has been requested but it has not been made available as of the date of this report.
 
Manufacturer Narrative
Per the clinic, the patient experienced a skin flap necrosis.Additional information has been requested but it has not been made available as of the date of this report.This report is submitted on may 31, 2023.
 
Manufacturer Narrative
Correction: the patient was treated with topical steroid and oral antibiotics after discharging from hospital, not topical and oral antibiotics as previously reported.Additional info: the implant magnet was replaced on (b)(6) 2023.This report is submitted on june 27, 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUCLEUS CI512 COCHLEAR IMPLANT WITH CONTOUR ADVANCE ELECTRODE
Type of Device
NUCLEUS 24 COCHLEAR IMPLANT SYSTEM
Manufacturer (Section D)
COCHLEAR LIMITED
1 university avenue
macquarie university
nsw 2109
AS  2109
Manufacturer (Section G)
COCHLEAR LTD
1 university avenue
macquarie university, nsw 2109
AS   2109
Manufacturer Contact
ken yian chow
unit ug-1, vertical podium
no. 8 jalan kerinchi
kuala lumpur, wilayah persekutuan 59200
MY   59200
MDR Report Key15541600
MDR Text Key301151413
Report Number6000034-2022-02931
Device Sequence Number1
Product Code MCM
UDI-Device Identifier09321502014564
UDI-Public(01)09321502014564(11)171005(17)191004
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P970051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 06/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/04/2019
Device Model NumberCI512
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/20/2022
Initial Date FDA Received10/05/2022
Supplement Dates Manufacturer Received09/20/2023
06/02/2023
Supplement Dates FDA Received05/31/2023
06/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/05/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-